Systematic screening of potential β-cell imaging agents

Biochemical and Biophysical Research Communications

Volumn 314, Issue 4, 2004, Pages 976-983

  Sweet, Ian R ^a   Cook, Daniel L ^a   Lernmark, Åke ^a   Greenbaum, Carla J ^b   Wallen, Angela R ^a   Marcum, Erin S ^a   Stekhova, Svetlana A ^a   Krohn, Kenneth A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Dithizone; Fluorodithizone; Glibenclamide; Pancreatic imaging agent; PET; Screening assay; Cell mass

Indexed keywords

DITHIZONE; DOPAMINE; FLUORODEOXYGLUCOSE; FLUORODITHIZONE; GLIBENCLAMIDE; LEVODOPA; NICOTINAMIDE; SEROTONIN; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; IMAGING SYSTEM; MOLECULE; NONHUMAN; PANCREAS ISLET BETA CELL; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RAT;

EID: 0942289897     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.182     Document Type: Article

References (22)

1. Bonner-Weir S. Regulation of pancreatic beta-cell mass in vivo. Recent Prog. Horm. Res. 49:1994;91-104.
2. Weir G.C., Bonner-Weir S., Leahy J.L. Islet mass and function in diabetes and transplantation. Diabetes. 39:1990;401-405.
3. Miki T., Nagashima K., Seino S. The structure and function of the ATP-sensitive K+ channel in insulin-secreting pancreatic beta-cells. J. Mol. Endocrinol. 22:1999;113-123.
4. Panten U., Schwanstecher M., Schwanstecher C. Sulfonylurea receptors and mechanism of sulfonylurea action. Exp. Clin. Endocrinol. Diabetes. 104:1996;1-9.
5. Ericson L.E., Hakanson R., Lundquist I. Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia. 13:1977;117-124.
6. Lernmark A. The significance of 5-hydroxytryptamine for insulin secretion in the mouse. Horm. Metab. Res. 3:1971;305-309.
7. Gylfe E. Serotonin as marker for the secretory granules in the pancreatic beta-cell. Acta Physiol. Scand. Suppl. 452:1977;125-128.
8. Hansen W.A., Christie M.R., Kahn R., Norgaard A., Abel I., Petersen A.M., Jorgensen D.W., Baekkeskov S., Nielsen J.H., Lernmark A.et al. Supravital dithizone staining in the isolation of human and rat pancreatic islets. Diabetes Res. 10:1989;53-57.
9. Tjalve H., Wilander E. The uptake in the pancreatic islets of nicotinamide, nicotinic acid and tryptophan and their ability to prevent streptozotocin diabetes in mice. Acta Endocrinol. (Copenh). 83:1976;357-364.
10. Asfari M., Janjic D., Meda P., Li G., Halban P.A., Wollheim C.B. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology. 130:1992;167-178.
11. Bieg S., Koike G., Jiang J., Klaff L., Pettersson A., MacMurray A.J., Jacob H.J., Lander E.S., Lernmark A. Genetic isolation of iddm 1 on chromosome 4 in the biobreeding (BB) rat. Mamm. Genome. 9:1998;324-326.
12. Matsumoto S., Shibata S., Kirchhof N. Immediate reversal of diabetes in primates following intraportal transplantation of porcine islets purified on a new histidine-lactoioniate-iodixanol gradient. Transplantation. 67:1999;S220.
13. Lieber M., Mazzetta J., Nelson-Rees W., Kaplan M., Todaro G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int. J. Cancer. 15:1975;741-747.
14. Gaines K.L., Hamilton S., Boyd III A.E. Characterization of the sulfonylurea receptor on beta cell membranes. J. Biol. Chem. 263:1988;2589-2592.
15. Ashcroft F.M. Mechanisms of the glycaemic effects of sulfonylureas. Horm. Metab. Res. 28:1996;456-463.
16. Moore A., Bonner-Weir S., Weissleder R. Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. Diabetes. 50:2001;2231-2236.
17. Garnuszek P., Licinska I., Fiedor P., Mazurek A.P. The synthesis, radioiodination and preliminary biological study of the new carboxylic derivatives of dithizone. Appl. Radiat. Isot. 49:1998;1563-1571.
18. Schirrmacker R., Weber M., Schmitz A., Shiue C.-Y., Alavi A.A., Peilen P., Schneider S., Kann P., Rosch F. Radiosynthesis of 1-(4-(2-[18F]fluoroethoxy) benzenesulfonyl)-3-butyl urea: a potential beta-cell imaging agent. J. Label Compd. Radiopharm. 45:2002;763-774.
19. Malaisse W.J. On the track to the beta-cell. Diabetologia. 44:2001;393-406.
20. D.-R. Hwang, V. Phan, Y. Huang, M. Laruelle, P. Jerabek, P. Fox, R. DeFronzo, Evaluation of [C-11]glyburide as a pancreatic beta-cell imaging agent., NIH Sponsored Workship: Imaging the Pancreatic Beta Cell. April 21-22 (2003).
21. Olsen K.M., Kearns G.L., Kemp S.F. Glyburide protein binding and the effect of albumin glycation in children, young adults, and older adults with diabetes. J. Clin. Pharmacol. 35:1995;739-745.
22. Bazin-Redureau M.I., Renard C.B., Scherrmann J.M. Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab')2 and Fab after intravenous administration in the rat. J. Pharm. Pharmacol. 49:1997;277-281.